Last reviewed · How we verify
Polycose
At a glance
| Generic name | Polycose |
|---|---|
| Also known as | Enteral Nutrition Formulas |
| Sponsor | McMaster University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Arginine Treatment for Alcoholic Hepatitis (Phase 2)
- Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring (NA)
- The Effects of 17β-estradiol on Skeletal Muscle Mass Following Immobilization (EARLY/Phase 1)
- Diet and Muscle Function In Older Adults (NA)
- Pilot Study: Tolerability of Feeding Different Doses of Bovine Milk Oligosaccharides for Modifying Gastrointestinal Function in Healthy Individuals (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Polycose CI brief — competitive landscape report
- Polycose updates RSS · CI watch RSS
- McMaster University portfolio CI